8-K 1 west_8k.txt =============================================================================== SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K current report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of earliest event reported: January 29, 2003 WEST PHARMACEUTICAL SERVICES, INC. (Exact name of registrant as specified in charter) Pennsylvania 1-8036 23-1210010 (State of Incorporation) (Commission File Number) I.R.S. Employer Identification No.) 101 Gordon Drive, P.O. Box 645, Lionville, Pennsylvania 19341-0645 (Address of Principal Executive Offices) (Zip Code) (610) 594-2900 (Registrant's telephone number, including area code) N/A (Former name or former address, if changed since last report) =============================================================================== ITEM 5. OTHER EVENTS. On February 11, 2003. West Pharmaceutical Services, Inc. (the "Company") issued a press release relating to an incident on January 29, 2003 at the Company's Kinston, North Carolina plant. The press release issued in connection with this incident is filed as exhibit 99.1 to this report and is incorporated herein by reference. ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS. (c) Exhibits: EXHIBIT # DESCRIPTION 99.1 Press Release dated February 11, 2003 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. WEST PHARMACEUTICAL SERVICES, INC. Date: February 13, 2003 By: ---------------------------------- Name: John R. Gailey III Title: Vice President EXHIBIT INDEX 99.1 Press Release dated February 11, 2003